Latest Views & News

Tom

Already 1/3 sold out: Shares, bears, croquet contest, salmon fishing, more shares, drink and pizza at Tom Winnifrith's farm at Sharestock on 10 September

Normally you sell 70% of the seats to an event in the seven weeks before the show. Here we are more than ten weeks from ShareStock and already one third of the seats are booked out. Fingers crossed the laws at the Grade Two listed farm on the banks of the River Dee on the Enland Wales border near Chester, will be pretty full on September 10th and why not as we have a great day on offer. Shares, prize croquet, salmon fishing, all day booze and home produced food, what better way to spend a Saturday in early September? 

PREMIUM CONTENT

Crestchic – a business trading momentum Buy?...

Having recently reached above 200p, shares in Northbridge Industrial Services, now Crestchic plc (LOAD), have fallen back to a current 200p offer price, £56.5 million market cap. However, recent corporate activity and trading mean we target a more than 250p share price within three months and here’s why.

Subscribe to ShareProphets to access Premium Content

Immotion – AGM update, just how “strong” is the trading?...

Previously writing on ‘immersive entertainment’ group Immotion (IMMO), with the shares rising above 6p in August last year I concluded that financial factors had seen me remain cautious and that with the market cap above £25 million I continued to avoid. So what of today a “pleased to provide” AGM trading update... and the shares at 3.7p?...

Bearcast
PREMIUM CONTENT

Tom Winnifrith Bearcast: V is for Vindication (Kefi, Verditek, Shield and the list today goes on and on)

In today's podcast I look at Optibiotix (OPTI) where I bought more shares today, Kefi Gold & Copper (Kefi), Guild ESports (GILD) asking if it and David Beckham are breaking up, Nanosynth (NNN), the shysters at Verditek (VDTK) and Shield Therapeutics. It is definately ouzo, or rather elderflower champagne, for supper tonight.

Subscribe to ShareProphets to access Premium Content

Microsaic Systems – “pleased to announce” trading update. Er, what about ‘profit’ & cash?

Microsaic Systems (MSYS) has issued a “pleased to announce” trading update, emphasising that “the launch of the Microsaic Services Division, earlier this year, has resulted in an uplift of 40% in revenues” and “a healthy order book for H2 2022 which is the strongest ever going in to the second half”. So what of a current little changed 0.08p share price, circa £5 million market capitalisation?...

Verditek – that ol’ contract win spoof works again – bailout placing achieved

Just how many times will mug punters fall for this spoofing?  Last Thursday shares in Verditek (VDTK) traded at 1.3p. On Friday they soared to 1.6p. On Monday there was a contract announced and they roofed it to 2.5p. Today…

Newsboy
PREMIUM CONTENT

Last day of June! What are house prices, Ocado and Moonpig up to?

It is the last day of June, the last day of the quarter and the last day of the first half of the year. How exciting! There is so much more to come for all active investors. As for the ‘buy a bit of everything / anything’ passive investor types…good luck, unless you really want to ignore the world of investments for a decade or two. And so much to think about, as always on a Thursday. First, I was amused to see that the latest Nationwide House Price Index for June pleased many people by still showing a year-on-year increase of 10.7% (only just below the 10.8% anticipated number).

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

EXPOSE: Supply@Me Capital - the state of its cash crisis

Today the fraud Supply@ME Capital (SYME) will hold its Annual General Meeting which amongst other things will authorise an increase in its authorised share capital so that it can issue additional shares to Venus Capital under the death spiral and issue shares to vendors of Tradeflow Capital to settle the deferred consideration.

Subscribe to ShareProphets to access Premium Content
STX
STX
PREMIUM CONTENT

100% Vindication for @TomWinnifrith: Shield Therapeutics admits to failed $30m placing, gets bailout loan but will still be bust by Christmas

Oh dear, oh dear, this is truly awful and explains why results which normally come out late April came out on deadline day today. Shield Therapeutics (STX) is in a mess as I warned so often. Ouzo for me. Cabbage water for those who ignored my explicit warnings and trolled and abused me instead.

Subscribe to ShareProphets to access Premium Content
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

|